Newsletter

Hong Kong and US IPO Weekly Report | Dingdang Health passed the Hong Kong Stock Exchange hearing, and Dajian Yuncang’s B2B trading platform was listed in the United States_Company_Submission_Inual Revenue

Original title: Hong Kong and US IPO Weekly Report | Dingdang Health passed the Hong Kong Stock Exchange hearing, and Dajian Yuncang’s B2B trading platform was listed in the US

Last week (August 18-August 21, 2022), 2 companies inListed in Hong Kong2China concept stocksexistUS stock market.

During the period, 1 company passed the Hong Kong Stock Exchange hearing, and 2 companies started the IPO.

Regarding the submission of forms, last week, one company submitted a form to the Hong Kong Stock ExchangeIPO listing, 1 Chinese concept stock filed a form with the SEC. Here is the full list:

one,List: Huide, the third SPAC company in the Hong Kong stock market, bought -Z and officially landed in the Hong Kong stock market

Last week, a total of 2 companies were listed on the Hong Kong stock market, namely Huide Acquisition-Z and Shuangcaizhuang.

Huide acquire-Z listed in Hong Kong

Huide Acquisition-Z The IPO is expected to issue 100 million shares,issue priceIt is HK$10 per share and 115,000 shares per lot.

The founders of the company are Chen Delin, Zeng Jingxuan and Juyi. All promoter shares will be held by Hong Kong Huide Limited, 51% owned by Extra Shine (wholly owned by Chen Delin), 32% by Pride Vision (wholly owned entirely to Zeng Jingxuan) and 17% by Juyi.

The company plans to focus on sustainable andCorporate GovernanceCompetitive advantage in terms of, and has operations or is expected to have operations in the Greater China regionFinancial Servicesor technology companies.

2. Hong Kong stock hearing and prospectus listing: Dingdang Health passed the Hong Kong Stock Exchange hearing

Last week, a total of 1 company passed the Hong Kong Stock Exchange hearing, and 2 companies started the IPO. Among them, China’s CDFG has closed the IPO.

Dingdang Health, a digital healthcare home service provider, passed the HKEx hearing

According to the Frost & Sullivan Report, in terms of revenue in 2021, the Company is a leading service provider in the digital retail pharmacy industry in China, ranking third in the industry with a market share of 1.0%.

Dingdang Health’s revenue mainly comes from pharmaceutical and health care business and others. Revenue from the pharmaceutical and healthcare business includes revenue generated from direct online sales, business distribution and offline retail, which together accounted for more than 95% of our revenue during the Track Record Period. Others mainly include marketing services, marketing services and other services.

Between 2018 and 2021 and the first quarter of 2022, the company’s revenue was 585 million yuan, 1.276 billion yuan, 2.229 billion yuan, 3.679 billion yuan and 987 million yuan respectively; in the same period, the loss and total comprehensive expenditure during the year were 103 million yuan, 274 million yuan, 920 million yuan, 1.6 billion yuan and 404 million yuan.

CDFG China closes IPO, listing imminent

CDFG China this timeThe final price for issuing foreign shares (H shares) is HK$158 per share and is expected to be listed on August 25, 2022.

According to Frost & Sullivan, backAccording to calculations, the company’s global ranking will be ranked first in the world in 2020 and 2021.

For the years ended 31 December 2019, 2020 and 2021, the company’s revenue was RMB 48.013 billion, 52.598 billion and 67.676 billion respectively, while the company’s revenueThey were 5.471 billion yuan, 7.109 billion yuan and 12.441 billion yuan respectively. From 2019 to 2021, the company’s revenue will grow at a CAGR of 18.7%, while the company’s net profit will grow at a CAGR of 50.8%.

three,US stock marketList: Dajian Yuncang is listed in the United States, and JD.com is a shareholder

Last week, a total of 2 Chinese concept stocks were listed on the US stock market, namely Dajian Yuncang and New Materials for the Stone Tram.

Dajian Yuncang, a B2B trading platform, landed on Nasdaq

The initial price of Dajian Yuncang was US$12.25, and 2.94 million Class A ordinary shares were issued. On the first day of listing, Dajian Yuncang rose more than 68% during the day. At the end of the day, Dajian Yuncang reported $15.69, up 28.08%, with a total market value of $624 million.

Dajian Cloud Warehouse is a B2B trading platform involved in the export of bulk goods. Dajian Cloud Warehouse focuses on international bulk commodity trade, transforms the traditional foreign trade industry through digital trade, and provides comprehensive online or offline cross-border handling and distribution services for global bulk commodities. The company launched GigaCloud Marketplace, a large-scale e-commerce platform under its Hong Kong subsidiary in 2019.

On the financial side, the company’s total revenue for 2019-2021 and the three months ending March 31, 2021 and March 31, 2022 were $122.3 million, $275.5 million, $414.2 million, $94.5 million, and $94.5 million , respectively; $112.4 million; income was $2.9 million, $37.5 million, $29.3 million, $8 million, and $4.7 million, respectively.

In the pre-listing shareholder structure, Jingdong accounted for 11.3%, and Red Star accounted for 7.9%.

4. List of US stock listing submissions: Hong Kong Information Global Engine Group submits a prospectus

Last week, one Chinese concept stock filed a prospectus with the SEC. Global Engine Group plans to issue 17 million ordinary shares under the name “GLE”.

The company is an integrated solutions provider that drives business results and innovation through the use of information and communications technology (“ICT”) solutions.

In the financial year ending June 30, 2021, the company’s revenue was HK$25.6 million, compared to HK$10 million in the same period last year; in the same period, net profit was HK$7 million, compared to HK$3.1 million in the same period last year.

5. Prospects for new shares this week

This week (August 22-August 28) it is expected that 2 companies will enterHong Kong IPOListed, there are no Chinese concept stocks listedUS stock IPOlisted.Return to Sohu, see more

Editor:

Disclaimer: The opinion of this article only represents the author himself, Sohu is an information publishing platform, and Sohu only provides information storage space services.